Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiography, Dual-Energy Scanned Projection | 23 | 2021 | 208 | 7.560 |
Why?
|
Tomography, X-Ray Computed | 81 | 2021 | 20659 | 3.730 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 24 | 2021 | 1224 | 2.650 |
Why?
|
Radiography, Abdominal | 13 | 2020 | 544 | 2.600 |
Why?
|
Carcinoma, Pancreatic Ductal | 7 | 2021 | 1758 | 2.120 |
Why?
|
Urolithiasis | 6 | 2019 | 123 | 2.060 |
Why?
|
Pancreatic Neoplasms | 12 | 2021 | 5444 | 1.950 |
Why?
|
Contrast Media | 41 | 2021 | 5329 | 1.870 |
Why?
|
Iodine | 8 | 2021 | 288 | 1.850 |
Why?
|
Liver Neoplasms | 15 | 2020 | 4353 | 1.570 |
Why?
|
Abdomen | 7 | 2020 | 1134 | 1.480 |
Why?
|
Adenocarcinoma | 8 | 2020 | 6364 | 1.320 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2020 | 2329 | 1.160 |
Why?
|
Body Size | 3 | 2019 | 459 | 1.030 |
Why?
|
Radiation Dosage | 11 | 2021 | 1944 | 0.910 |
Why?
|
Artifacts | 7 | 2021 | 1893 | 0.870 |
Why?
|
Crohn Disease | 5 | 2020 | 2283 | 0.850 |
Why?
|
Perfusion Imaging | 3 | 2015 | 193 | 0.830 |
Why?
|
Abdominal Neoplasms | 3 | 2019 | 284 | 0.800 |
Why?
|
Diverticulitis, Colonic | 2 | 2021 | 140 | 0.790 |
Why?
|
Urinary Calculi | 3 | 2019 | 81 | 0.770 |
Why?
|
Deglutition Disorders | 2 | 2019 | 639 | 0.770 |
Why?
|
Gastrointestinal Diseases | 2 | 2020 | 1203 | 0.770 |
Why?
|
Abdominal Pain | 7 | 2020 | 1069 | 0.760 |
Why?
|
Diagnostic Imaging | 7 | 2020 | 3529 | 0.740 |
Why?
|
Kidney Calculi | 4 | 2016 | 457 | 0.630 |
Why?
|
Radiation Protection | 3 | 2013 | 424 | 0.620 |
Why?
|
Urography | 2 | 2017 | 316 | 0.620 |
Why?
|
Kidney Neoplasms | 5 | 2020 | 4274 | 0.600 |
Why?
|
Pancreatitis, Chronic | 1 | 2020 | 282 | 0.560 |
Why?
|
Radiographic Image Enhancement | 7 | 2019 | 872 | 0.550 |
Why?
|
Magnetic Resonance Imaging | 17 | 2020 | 36532 | 0.550 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2016 | 25 | 0.520 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2021 | 730 | 0.490 |
Why?
|
Gallbladder Neoplasms | 2 | 2021 | 189 | 0.490 |
Why?
|
Pancreas | 4 | 2021 | 1700 | 0.470 |
Why?
|
Metals | 1 | 2019 | 710 | 0.460 |
Why?
|
Humans | 121 | 2021 | 765968 | 0.450 |
Why?
|
Ultrasonography | 7 | 2018 | 5993 | 0.440 |
Why?
|
Retrospective Studies | 39 | 2021 | 81514 | 0.430 |
Why?
|
Fiducial Markers | 1 | 2015 | 134 | 0.430 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2020 | 888 | 0.430 |
Why?
|
Urinary Tract | 1 | 2016 | 305 | 0.420 |
Why?
|
Immunotherapy | 2 | 2020 | 4752 | 0.420 |
Why?
|
Portal Vein | 4 | 2020 | 435 | 0.410 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 561 | 0.400 |
Why?
|
Radiography, Interventional | 4 | 2017 | 1129 | 0.400 |
Why?
|
Diagnosis, Differential | 18 | 2021 | 12976 | 0.390 |
Why?
|
Aged, 80 and over | 33 | 2021 | 59489 | 0.390 |
Why?
|
Cranial Fossa, Middle | 1 | 2012 | 29 | 0.390 |
Why?
|
Prostheses and Implants | 1 | 2019 | 1273 | 0.390 |
Why?
|
Mesenchymoma | 1 | 2012 | 50 | 0.380 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 654 | 0.380 |
Why?
|
Celiac Plexus | 1 | 2011 | 34 | 0.380 |
Why?
|
Sarcoma | 4 | 2015 | 1802 | 0.370 |
Why?
|
Documentation | 1 | 2018 | 916 | 0.370 |
Why?
|
Middle Aged | 62 | 2021 | 223009 | 0.370 |
Why?
|
Evidence-Based Medicine | 10 | 2020 | 3685 | 0.360 |
Why?
|
Autonomic Nerve Block | 1 | 2011 | 84 | 0.360 |
Why?
|
Pain, Intractable | 1 | 2011 | 132 | 0.350 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2011 | 70 | 0.350 |
Why?
|
Surgery, Computer-Assisted | 2 | 2015 | 993 | 0.350 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 595 | 0.340 |
Why?
|
Sensitivity and Specificity | 11 | 2021 | 14652 | 0.340 |
Why?
|
Cholelithiasis | 1 | 2011 | 407 | 0.340 |
Why?
|
Radiology | 2 | 2020 | 2090 | 0.340 |
Why?
|
Early Detection of Cancer | 4 | 2020 | 3236 | 0.340 |
Why?
|
Aged | 49 | 2021 | 171117 | 0.330 |
Why?
|
Polyps | 1 | 2011 | 200 | 0.330 |
Why?
|
Intestines | 1 | 2018 | 1906 | 0.330 |
Why?
|
Sarcopenia | 3 | 2018 | 378 | 0.310 |
Why?
|
Pelvic Neoplasms | 1 | 2011 | 247 | 0.310 |
Why?
|
Skull Base Neoplasms | 1 | 2012 | 276 | 0.300 |
Why?
|
Male | 66 | 2021 | 363698 | 0.290 |
Why?
|
Microspheres | 1 | 2011 | 773 | 0.290 |
Why?
|
Lymphoma | 1 | 2016 | 1897 | 0.280 |
Why?
|
Iopamidol | 3 | 2018 | 188 | 0.280 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2878 | 0.280 |
Why?
|
Camptothecin | 1 | 2011 | 600 | 0.280 |
Why?
|
Gadolinium DTPA | 2 | 2020 | 823 | 0.280 |
Why?
|
Colonography, Computed Tomographic | 2 | 2019 | 170 | 0.270 |
Why?
|
Algorithms | 6 | 2021 | 14071 | 0.270 |
Why?
|
Female | 64 | 2021 | 396112 | 0.260 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 1661 | 0.260 |
Why?
|
Adult | 44 | 2021 | 223044 | 0.260 |
Why?
|
Positron-Emission Tomography | 4 | 2016 | 6547 | 0.250 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2016 | 2798 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3223 | 0.250 |
Why?
|
Societies, Medical | 8 | 2020 | 3956 | 0.240 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2659 | 0.240 |
Why?
|
Carcinoma, Renal Cell | 1 | 2020 | 3181 | 0.240 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2021 | 8923 | 0.230 |
Why?
|
Neoplasms | 5 | 2021 | 22340 | 0.230 |
Why?
|
Neoplasm Staging | 4 | 2020 | 11206 | 0.220 |
Why?
|
Barium Sulfate | 2 | 2017 | 180 | 0.220 |
Why?
|
Reproducibility of Results | 10 | 2021 | 20124 | 0.210 |
Why?
|
Predictive Value of Tests | 10 | 2019 | 15398 | 0.210 |
Why?
|
Angiogenesis Inhibitors | 5 | 2015 | 2056 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.200 |
Why?
|
Colitis, Ulcerative | 3 | 2019 | 1915 | 0.200 |
Why?
|
Ureteral Calculi | 2 | 2017 | 112 | 0.200 |
Why?
|
Kidney Medulla | 2 | 2014 | 169 | 0.190 |
Why?
|
Feasibility Studies | 4 | 2021 | 5302 | 0.180 |
Why?
|
Biliary Tract Neoplasms | 2 | 2015 | 186 | 0.180 |
Why?
|
Barium | 2 | 2019 | 62 | 0.180 |
Why?
|
Physicians | 1 | 2018 | 4588 | 0.180 |
Why?
|
Gastrostomy | 2 | 2015 | 327 | 0.170 |
Why?
|
Obesity | 3 | 2019 | 13076 | 0.170 |
Why?
|
Cryptococcus neoformans | 1 | 2020 | 110 | 0.170 |
Why?
|
Cryptococcosis | 1 | 2020 | 99 | 0.170 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13648 | 0.170 |
Why?
|
Abdominal Cavity | 1 | 2019 | 33 | 0.170 |
Why?
|
Colorectal Neoplasms | 4 | 2020 | 6942 | 0.160 |
Why?
|
Enterocolitis | 1 | 2020 | 107 | 0.160 |
Why?
|
Iodine Compounds | 1 | 2018 | 28 | 0.160 |
Why?
|
Whole Body Imaging | 1 | 2021 | 281 | 0.150 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2018 | 3356 | 0.150 |
Why?
|
Colon | 2 | 2019 | 1795 | 0.150 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7425 | 0.150 |
Why?
|
Diverticulitis | 1 | 2021 | 187 | 0.150 |
Why?
|
Abdomen, Acute | 1 | 2018 | 121 | 0.150 |
Why?
|
Ureteroscopy | 2 | 2017 | 140 | 0.140 |
Why?
|
Laparotomy | 1 | 2020 | 460 | 0.140 |
Why?
|
Utilization Review | 1 | 2019 | 381 | 0.140 |
Why?
|
Osteochondroma | 1 | 2007 | 44 | 0.140 |
Why?
|
Lipomatosis, Multiple Symmetrical | 1 | 2007 | 8 | 0.140 |
Why?
|
Software | 6 | 2018 | 4462 | 0.140 |
Why?
|
Iliac Artery | 1 | 2018 | 330 | 0.140 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 520 | 0.140 |
Why?
|
Image Enhancement | 4 | 2012 | 2858 | 0.140 |
Why?
|
Adolescent | 12 | 2020 | 88835 | 0.140 |
Why?
|
Vagus Nerve Diseases | 1 | 2006 | 5 | 0.140 |
Why?
|
Mandibular Condyle | 1 | 2007 | 118 | 0.140 |
Why?
|
Mesentery | 1 | 2017 | 199 | 0.140 |
Why?
|
United States | 12 | 2020 | 72903 | 0.140 |
Why?
|
Pharyngeal Neoplasms | 1 | 2007 | 113 | 0.130 |
Why?
|
Omentum | 1 | 2017 | 165 | 0.130 |
Why?
|
Mandibular Neoplasms | 1 | 2007 | 131 | 0.130 |
Why?
|
Young Adult | 11 | 2020 | 59889 | 0.130 |
Why?
|
Neoadjuvant Therapy | 4 | 2015 | 2895 | 0.130 |
Why?
|
Aorta, Abdominal | 1 | 2018 | 596 | 0.130 |
Why?
|
Neovascularization, Pathologic | 4 | 2015 | 2631 | 0.120 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2006 | 131 | 0.120 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2016 | 220 | 0.120 |
Why?
|
Ureteral Obstruction | 1 | 2017 | 291 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2020 | 866 | 0.120 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 834 | 0.120 |
Why?
|
Ethanol | 2 | 2011 | 1323 | 0.110 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2016 | 193 | 0.110 |
Why?
|
Colonic Polyps | 1 | 2019 | 556 | 0.110 |
Why?
|
Steroids | 1 | 2019 | 933 | 0.110 |
Why?
|
Tumor Burden | 2 | 2017 | 1885 | 0.110 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 536 | 0.110 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1315 | 0.110 |
Why?
|
Ablation Techniques | 1 | 2016 | 254 | 0.100 |
Why?
|
Connective Tissue | 1 | 2015 | 425 | 0.100 |
Why?
|
Goiter, Endemic | 1 | 2002 | 3 | 0.100 |
Why?
|
Salts | 1 | 2002 | 60 | 0.100 |
Why?
|
Salvage Therapy | 1 | 2019 | 1272 | 0.100 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 904 | 0.100 |
Why?
|
Cholecystolithiasis | 1 | 2011 | 7 | 0.100 |
Why?
|
Liver | 4 | 2020 | 7562 | 0.100 |
Why?
|
Zygoma | 1 | 2012 | 52 | 0.100 |
Why?
|
Gene Amplification | 1 | 2016 | 1091 | 0.100 |
Why?
|
Appendicitis | 1 | 2018 | 679 | 0.100 |
Why?
|
Phenol | 1 | 2011 | 45 | 0.090 |
Why?
|
Neurilemmoma | 1 | 2006 | 522 | 0.090 |
Why?
|
Cholangiocarcinoma | 1 | 2016 | 578 | 0.090 |
Why?
|
Bile Duct Neoplasms | 1 | 2016 | 626 | 0.090 |
Why?
|
Injections | 2 | 2011 | 840 | 0.090 |
Why?
|
Rhabdomyolysis | 1 | 2012 | 151 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2020 | 2054 | 0.090 |
Why?
|
Esophagus | 1 | 2016 | 1037 | 0.090 |
Why?
|
Diatrizoate Meglumine | 1 | 2010 | 80 | 0.090 |
Why?
|
Surgical Mesh | 1 | 2013 | 315 | 0.090 |
Why?
|
Device Removal | 1 | 2015 | 646 | 0.090 |
Why?
|
Treatment Outcome | 9 | 2018 | 65188 | 0.090 |
Why?
|
Quadriceps Muscle | 1 | 2012 | 157 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2019 | 1159 | 0.090 |
Why?
|
Technology, Radiologic | 1 | 2011 | 158 | 0.090 |
Why?
|
Maxillary Sinus | 1 | 2012 | 172 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1434 | 0.090 |
Why?
|
Acute Disease | 1 | 2021 | 7232 | 0.090 |
Why?
|
Colonoscopy | 1 | 2018 | 1406 | 0.080 |
Why?
|
Prospective Studies | 7 | 2021 | 54802 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 961 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 822 | 0.080 |
Why?
|
Simvastatin | 1 | 2012 | 345 | 0.080 |
Why?
|
Cholecystectomy | 1 | 2011 | 407 | 0.080 |
Why?
|
Necrosis | 2 | 2011 | 1617 | 0.080 |
Why?
|
Subtraction Technique | 1 | 2012 | 512 | 0.080 |
Why?
|
Colectomy | 3 | 2019 | 697 | 0.080 |
Why?
|
Scattering, Radiation | 1 | 2011 | 482 | 0.080 |
Why?
|
Gallstones | 1 | 2011 | 285 | 0.080 |
Why?
|
Cystadenoma, Serous | 1 | 2009 | 99 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11868 | 0.080 |
Why?
|
Swine | 4 | 2011 | 5988 | 0.070 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 2015 | 1643 | 0.070 |
Why?
|
Organoplatinum Compounds | 3 | 2018 | 404 | 0.070 |
Why?
|
Meningioma | 1 | 2007 | 1221 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2015 | 950 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1421 | 0.070 |
Why?
|
Emergencies | 3 | 2019 | 1223 | 0.070 |
Why?
|
Quality Control | 2 | 2021 | 837 | 0.070 |
Why?
|
Temporal Bone | 1 | 2012 | 683 | 0.070 |
Why?
|
Ultrasonography, Interventional | 2 | 2017 | 1531 | 0.070 |
Why?
|
Intestine, Small | 1 | 2013 | 1214 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5876 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5526 | 0.070 |
Why?
|
Mandible | 1 | 2012 | 746 | 0.070 |
Why?
|
Paralysis | 1 | 2008 | 248 | 0.070 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1292 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1327 | 0.070 |
Why?
|
Mass Screening | 2 | 2020 | 5446 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4034 | 0.070 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1377 | 0.070 |
Why?
|
Radiology Information Systems | 1 | 2011 | 532 | 0.060 |
Why?
|
Ureter | 1 | 2008 | 364 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2015 | 2024 | 0.060 |
Why?
|
Radiometry | 1 | 2011 | 804 | 0.060 |
Why?
|
Time Factors | 6 | 2018 | 40065 | 0.060 |
Why?
|
Kidney | 2 | 2019 | 7066 | 0.060 |
Why?
|
Workload | 1 | 2011 | 851 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2019 | 9373 | 0.060 |
Why?
|
Pancreatectomy | 1 | 2009 | 820 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 3047 | 0.060 |
Why?
|
Radiopharmaceuticals | 2 | 2015 | 2699 | 0.060 |
Why?
|
Urban Population | 1 | 2002 | 2040 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9338 | 0.060 |
Why?
|
Edema | 1 | 2008 | 760 | 0.060 |
Why?
|
Biological Products | 1 | 2013 | 942 | 0.060 |
Why?
|
Prognosis | 3 | 2020 | 29922 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8703 | 0.050 |
Why?
|
Fatty Liver | 1 | 2009 | 807 | 0.050 |
Why?
|
Fluoroscopy | 2 | 2018 | 947 | 0.050 |
Why?
|
Genetic Testing | 1 | 2016 | 3595 | 0.050 |
Why?
|
Pancreatitis | 1 | 2009 | 1087 | 0.050 |
Why?
|
Risk Factors | 5 | 2021 | 74840 | 0.050 |
Why?
|
Risk Assessment | 3 | 2020 | 24282 | 0.050 |
Why?
|
Endoscopy | 2 | 2009 | 1841 | 0.050 |
Why?
|
Hospitalization | 2 | 2019 | 10808 | 0.050 |
Why?
|
Treatment Failure | 2 | 2019 | 2652 | 0.050 |
Why?
|
Soft Tissue Neoplasms | 1 | 2010 | 1165 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5337 | 0.050 |
Why?
|
Child | 5 | 2018 | 80564 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39193 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2021 | 26346 | 0.040 |
Why?
|
Spinal Cord Injuries | 1 | 2008 | 927 | 0.040 |
Why?
|
Quality Improvement | 1 | 2015 | 3853 | 0.040 |
Why?
|
Physics | 1 | 2020 | 92 | 0.040 |
Why?
|
Spinal Cord | 1 | 2008 | 1784 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 2172 | 0.040 |
Why?
|
Computer Simulation | 2 | 2010 | 6255 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4900 | 0.040 |
Why?
|
ROC Curve | 2 | 2019 | 3620 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15842 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8611 | 0.040 |
Why?
|
Cerebrovascular Circulation | 1 | 2009 | 2674 | 0.040 |
Why?
|
Mutation | 3 | 2020 | 30198 | 0.040 |
Why?
|
Exostoses | 1 | 2007 | 30 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8237 | 0.040 |
Why?
|
Laparoscopy | 1 | 2009 | 2039 | 0.040 |
Why?
|
Radiography, Panoramic | 1 | 2007 | 110 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2009 | 3312 | 0.040 |
Why?
|
Parotid Region | 1 | 2007 | 1 | 0.040 |
Why?
|
Phantoms, Imaging | 2 | 2017 | 2475 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 460 | 0.040 |
Why?
|
Transcription Factor TFIIIA | 1 | 2016 | 24 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3251 | 0.030 |
Why?
|
Lymphangioma, Cystic | 1 | 2007 | 34 | 0.030 |
Why?
|
Mandibular Diseases | 1 | 2007 | 117 | 0.030 |
Why?
|
Administration, Oral | 2 | 2017 | 4015 | 0.030 |
Why?
|
Observer Variation | 2 | 2015 | 2615 | 0.030 |
Why?
|
Leucovorin | 1 | 2018 | 641 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2016 | 109 | 0.030 |
Why?
|
Drug Substitution | 1 | 2019 | 292 | 0.030 |
Why?
|
Deoxycytidine | 2 | 2012 | 889 | 0.030 |
Why?
|
Postoperative Period | 1 | 2021 | 1816 | 0.030 |
Why?
|
Quality of Life | 1 | 2017 | 13462 | 0.030 |
Why?
|
Animals | 5 | 2017 | 168764 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1831 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2018 | 548 | 0.030 |
Why?
|
Mediastinum | 1 | 2007 | 271 | 0.030 |
Why?
|
Pelvis | 1 | 2020 | 738 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2013 | 2865 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2017 | 683 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 561 | 0.030 |
Why?
|
Postoperative Complications | 5 | 2017 | 15747 | 0.030 |
Why?
|
Tomography, Spiral Computed | 1 | 2006 | 273 | 0.030 |
Why?
|
Parotid Neoplasms | 1 | 2006 | 157 | 0.030 |
Why?
|
Pregnancy | 1 | 2016 | 30260 | 0.030 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2007 | 226 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 42500 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18071 | 0.030 |
Why?
|
Gene Fusion | 1 | 2016 | 357 | 0.030 |
Why?
|
Pharynx | 1 | 2006 | 436 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1731 | 0.030 |
Why?
|
Fluorouracil | 1 | 2018 | 1648 | 0.030 |
Why?
|
Workflow | 1 | 2018 | 862 | 0.030 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 623 | 0.030 |
Why?
|
Equipment Failure | 1 | 2015 | 578 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13451 | 0.030 |
Why?
|
Drug Resistance | 1 | 2019 | 1591 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9249 | 0.030 |
Why?
|
Fluorine Radioisotopes | 1 | 2015 | 397 | 0.030 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2012 | 110 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2017 | 1133 | 0.020 |
Why?
|
Diarrhea | 1 | 2019 | 1316 | 0.020 |
Why?
|
Neck | 1 | 2007 | 733 | 0.020 |
Why?
|
Ileus | 1 | 2012 | 65 | 0.020 |
Why?
|
Creatinine | 1 | 2017 | 1915 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2020 | 2132 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2016 | 1028 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2018 | 10429 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2018 | 2210 | 0.020 |
Why?
|
Stomach | 1 | 2013 | 699 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2012 | 413 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4056 | 0.020 |
Why?
|
Radiography | 2 | 2010 | 6919 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3426 | 0.020 |
Why?
|
Adiposity | 1 | 2018 | 1890 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2018 | 7875 | 0.020 |
Why?
|
Gastroscopy | 1 | 2010 | 213 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26318 | 0.020 |
Why?
|
Body Mass Index | 2 | 2018 | 13039 | 0.020 |
Why?
|
Muscular Diseases | 1 | 2012 | 550 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2012 | 2229 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2013 | 784 | 0.020 |
Why?
|
Leg | 1 | 2012 | 1080 | 0.020 |
Why?
|
Electromyography | 1 | 2012 | 1399 | 0.020 |
Why?
|
Pressure | 1 | 2010 | 1168 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9747 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12795 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2010 | 1381 | 0.020 |
Why?
|
Microvessels | 1 | 2010 | 591 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2267 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4209 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2012 | 1195 | 0.020 |
Why?
|
Physical Examination | 1 | 2012 | 1266 | 0.020 |
Why?
|
India | 1 | 2002 | 2334 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1403 | 0.020 |
Why?
|
Endosonography | 1 | 2009 | 626 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3430 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1407 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2012 | 1316 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 3111 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 3513 | 0.010 |
Why?
|
Program Evaluation | 1 | 2002 | 2499 | 0.010 |
Why?
|
Demography | 1 | 2008 | 1641 | 0.010 |
Why?
|
Models, Animal | 1 | 2009 | 2120 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10070 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2007 | 2921 | 0.010 |
Why?
|
Palliative Care | 1 | 2017 | 3645 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2015 | 2788 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13632 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6203 | 0.010 |
Why?
|
Body Weight | 1 | 2012 | 4622 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2009 | 15880 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2010 | 18293 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6832 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6499 | 0.010 |
Why?
|
Recovery of Function | 1 | 2008 | 2966 | 0.010 |
Why?
|
Pain | 1 | 2012 | 5077 | 0.010 |
Why?
|
Hemorrhage | 1 | 2008 | 3461 | 0.010 |
Why?
|
Pilot Projects | 1 | 2008 | 8733 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12509 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12056 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9525 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 22223 | 0.010 |
Why?
|